AMGN vs BAM · P/E 24, rev $10.05B vs P/E 31, rev $4.82B
Amgen Inc (AMGN) versus Brookfield Asset Management Ltd. (BAM) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Brookfield Asset Management Ltd. (BAM) is a asset management company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported BAM revenue for 2025-12-31 was $4.82B. Net income was $2.40B. Revenue was up 21.0% from 2024-12-31 to 2025-12-31. BAM currently screens at market cap $78.23B and trailing P/E 31.4.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. BAM currently screens at market cap $78.23B and trailing P/E 31.4.
Not investment advice. Open the AMGN and BAM stock pages for the full models.
Not investment advice.